Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

525 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pan-cancer image-based detection of clinically actionable genetic alterations.
Kather JN, Heij LR, Grabsch HI, Loeffler C, Echle A, Muti HS, Krause J, Niehues JM, Sommer KAJ, Bankhead P, Kooreman LFS, Schulte JJ, Cipriani NA, Buelow RD, Boor P, Ortiz-Brüchle NN, Hanby AM, Speirs V, Kochanny S, Patnaik A, Srisuwananukorn A, Brenner H, Hoffmeister M, van den Brandt PA, Jäger D, Trautwein C, Pearson AT, Luedde T. Kather JN, et al. Among authors: patnaik a. Nat Cancer. 2020 Aug;1(8):789-799. doi: 10.1038/s43018-020-0087-6. Epub 2020 Jul 27. Nat Cancer. 2020. PMID: 33763651 Free PMC article.
Author Correction: Pan-cancer image-based detection of clinically actionable genetic alterations.
Kather JN, Heij LR, Grabsch HI, Loeffler C, Echle A, Muti HS, Krause J, Niehues JM, Sommer KAJ, Bankhead P, Kooreman LFS, Schulte JJ, Cipriani NA, Buelow RD, Boor P, Ortiz-Brüchle N, Hanby AM, Speirs V, Kochanny S, Patnaik A, Srisuwananukorn A, Brenner H, Hoffmeister M, van den Brandt PA, Jäger D, Trautwein C, Pearson AT, Luedde T. Kather JN, et al. Among authors: patnaik a. Nat Cancer. 2020 Nov;1(11):1129. doi: 10.1038/s43018-020-00149-6. Nat Cancer. 2020. PMID: 35122072 No abstract available.
Suppression of Tumor Cell Lactate-generating Signaling Pathways Eradicates Murine PTEN/p53-deficient Aggressive-variant Prostate Cancer via Macrophage Phagocytosis.
Chaudagar K, Hieromnimon HM, Kelley A, Labadie B, Shafran J, Rameshbabu S, Drovetsky C, Bynoe K, Solanki A, Markiewicz E, Fan X, Loda M, Patnaik A. Chaudagar K, et al. Among authors: patnaik a. Clin Cancer Res. 2023 Dec 1;29(23):4930-4940. doi: 10.1158/1078-0432.CCR-23-1441. Clin Cancer Res. 2023. PMID: 37721526 Free PMC article.
Mouse Models for Cancer Immunotherapy Research.
Olson B, Li Y, Lin Y, Liu ET, Patnaik A. Olson B, et al. Among authors: patnaik a. Cancer Discov. 2018 Nov;8(11):1358-1365. doi: 10.1158/2159-8290.CD-18-0044. Epub 2018 Oct 11. Cancer Discov. 2018. PMID: 30309862 Free PMC article. Review.
Author Correction: A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer.
Lunardi A, Ala U, Epping MT, Salmena L, Clohessy JG, Webster KA, Wang G, Mazzucchelli R, Bianconi M, Stack EC, Lis R, Patnaik A, Cantley LC, Bubley G, Cordon-Cardo C, Gerald WL, Montironi R, Signoretti S, Loda M, Nardella C, Pandolfi PP. Lunardi A, et al. Among authors: patnaik a. Nat Genet. 2020 Oct;52(10):1132. doi: 10.1038/s41588-020-0701-7. Nat Genet. 2020. PMID: 32884149
Antihistamine Drug Ebastine Inhibits Cancer Growth by Targeting Polycomb Group Protein EZH2.
Li Q, Liu KY, Liu Q, Wang G, Jiang W, Meng Q, Yi Y, Yang Y, Wang R, Zhu S, Li C, Wu L, Zhao D, Yan L, Zhang L, Kim JS, Zu X, Kozielski AJ, Qian W, Chang JC, Patnaik A, Chen K, Cao Q. Li Q, et al. Among authors: patnaik a. Mol Cancer Ther. 2020 Oct;19(10):2023-2033. doi: 10.1158/1535-7163.MCT-20-0250. Epub 2020 Aug 27. Mol Cancer Ther. 2020. PMID: 32855270 Free PMC article.
Targeting Innate Immunity in Cancer Therapy.
Rameshbabu S, Labadie BW, Argulian A, Patnaik A. Rameshbabu S, et al. Among authors: patnaik a. Vaccines (Basel). 2021 Feb 9;9(2):138. doi: 10.3390/vaccines9020138. Vaccines (Basel). 2021. PMID: 33572196 Free PMC article. Review.
Utilization of Next-Generation Sequencing in Conjunction With Immunohistochemistry to Predict Exceptional Response to Combination Immune Checkpoint Therapy in a Heavily Pretreated Patient With Castration-Resistant Prostate Cancer.
Reizine N, Socco S, Weng E, Atueyi U, Mehta V, Patnaik A. Reizine N, et al. Among authors: patnaik a. JCO Precis Oncol. 2023 Mar;7:e2200483. doi: 10.1200/PO.22.00483. JCO Precis Oncol. 2023. PMID: 36996374 No abstract available.
PI3K enters beta-testing.
Shaywitz AJ, Courtney KD, Patnaik A, Cantley LC. Shaywitz AJ, et al. Among authors: patnaik a. Cell Metab. 2008 Sep;8(3):179-81. doi: 10.1016/j.cmet.2008.08.011. Cell Metab. 2008. PMID: 18762017 Free PMC article. Review.
525 results